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The biological action of N-acetyl-p-aminophenol - paracetamol (acetaminophen) has been
demonstrated to involve different mechanisms and is still not clear. Hydrogen sulfide (H2S)has been shown to play an important role in many physiological and pathological processes
including nociception. The interaction between acetaminophen and endogenous H2S isunknown. Twenty four female CBA strain mice were administered intraperitoneal injections
of N-acetyl-p-aminophenol solution: paracetemol in doses of 30 mg/kg b.w. per day (group
D1, n = 8) or 100 mg/kg b.w. per day (group D2, n = 8).. The control group (n = 8) received
physiological saline in portions of the same volume  0.2 ml. The measurements of tissue H2Sconcentration were performed with the Siegel spectrophotometric modified method. In the
brain, the H2S tissue level decreased, but more significantly in the lower drug dose group.Conversely, there was a significant rise in the H2S tissue concentration in D1 and D2 groupsin heart and kidney with the increase more pronounced in the group with the lower
paracetamol dose. In the liver only the higher acetaminophen dose elicited a change in H2Sconcentration, increasing after administration of acetaminophen at 100 mg/kg. Our study
demonstrates that paracetamol induces H2S tissue concentration changes in different mouseorgans.
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N-acetyl-p-aminophenol – paracetamol (aceta-
minophen) is an example of a paradox in medicine.
Despite lacking basic knowledge of the mecha-
nisms of action of paracetamol, its antipyretic and
analgetic properties have been successfully used,
including pediatrics and over-the-counter sale, for
over 50 years (BERTOLINI et al. 2006). Also para-
doxically, studies of the recent decade have
changed the perception of hydrogen sulfide (H2S)
from a rotten egg odorous poisonous gas to a ‘gas-
otransmitter’ and an important co-regulator of nu-
merous endogenous processes in mammals
(£OWICKA & BE£TOWSKI 2007). Since paraceta-
mol affects some processes that H2S is recognized
to co-modulate, like nociception, the question
arises if the biology of acetaminophen involves
H2S (LEE et al. 2008). The influence of paraceta-
mol on H2S generation and the role of the gaso-
transmitter in the biological effects of the drug are
unknown. The aim of this study was to assess the
impact of acetaminophen on the tissue H2S con-
centration in mouse brain, heart, liver and kidney.
_______________________________________
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Material and Methods
Animals
Twenty four CBA strain female mice (3-4 month
old individuals) of approximate 20 g weight were
involved in the study. The animals were housed
under standard laboratory conditions and had free
access to water and food. They were kept at a tempera-
ture of 22-24°C with a light/dark cycle of 12 h.
Study protocol
The study has been performed in accordance
with the guidelines for the care and use of labora-
tory animals accepted by the Bioethical Committee
of the Jagiellonian University Medical College.
The study design comprised intraperitoneal ad-
ministration of N-acetyl-p-aminophenol of 30 mg/ kg
body weight per day (0.6 mg/d – group D1, n = 8)
or 100 mg/kg body weight per day (2.0 mg/d – group
D2, n = 8) for 5 consecutive days at the same time
of the day (10:30 am). N-acetyl-p-aminophenol
(Paracetamol, Biofarm, Poland) was dissolved in
physiological saline (each injection contained 0.2
ml of the solution). The control group (n = 8) re-
ceived intraperitoneally physiological saline in
portions of the same volume. The individuals were
randomly assigned to each group. The animals tol-
erated the applied doses of paracetamol well and
remained in good condition till the end of the ex-
periment. Measurements of H2S concentration
were performed by the use of the modified method
of Siegel (SIEGEL 1965; SOMOGYI et al. 2008).
Tissue sample preparation
The animals were killed by cervical dislocation 2
hours after the last drug or physiological saline in-
jection. Their brains, hearts, livers and kidneys were
quickly removed and homogenized with 0.01 mol/l
sodium hydroxide (NaOH): brain tissue in propor-
tion of 1 to 3, liver of 1 to 5, heart and kidney of
1 to 10 and frozen. Then 50% trichloroacetic acid
(TCA) was added (0.5 ml to 2 g of brain or liver
samples in tight capsules of 3 ml and 0.25 ml to 1 g
of heart or kidney samples in tight capsules of 2 ml),
the suspension was shaken and centrifuged. Sub-
sequently, 1.5 ml of brain or liver and 0.75 ml heart
or kidney supernatant samples were moved to 2 ml
tight capsules with 0.15 ml or 0.075 ml of 0.02
mol/l N,N-dimethyl-p-phenyl-diamine sulfate in
7.2 mol/l hydrochloric acid (HCl), then 0.15 ml or
0.075 ml of 0.03 mol/l iron (III) chloride (FeCl3) in
1.2 mol/l HCl portions were added, respectively.
After 20 minutes in darkness the content was
shaken for 1 minute with 1 ml of chloroform.
H2S tissue concentration measurement
Absorbance was measured at 650 nm with the
Varian Cary 100 spectrophotometer. A standard
curve was prepared with an iodometrically deter-
mined 0.0001 mol/l sodium sulfide (Na2S) solu-
tion. For each group of animals four concurrent
analyses of every analyzed tissue type were per-
formed.
Statistical analysis
Statistical analysis was performed within the R
Environment by the Student’s t-test. Statistical
significance was considered when P<0.05.
Results and Discussion
There was a significant rise in the H2S tissue
concentration in D1 and D2 groups in the heart and
kidney, the increase was more pronounced in the
group with the lower paracetamol dose as com-
pared to the group of drug higher dose. Con-
versely, in the brain the H2S tissue level decreased
but more in the lower acetaminophen dose group.
In the liver only a higher paracetamol dose evoked
a H2S concentration change, i.e. its level increased
after 100 mg/kg of acetaminophen administration.
The results are presented in Table 1.
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Table 1
Hydrogen sulfide (H2S) tissue concentrations in mouse brain, heart, liver and kidney following














Brain 1.47 ± 0.02 0.80 ± 0.02 <0.01 1.05 ± 0.02 <0.01
Heart 6.89 ± 0.14 8.12 ± 0.16 <0.01 7.35 ± 0.10 <0.01
Liver 3.92 ± 0.06 3.95 ± 0.07 0.54 4.65 ± 0.09 <0.01
Kidney 7.13 ± 0.07 9.60 ± 0.14 <0.01 8.36 ± 0.14 <0.01
A debate about paracetamol’s primary site of ac-
tion has been ongoing in the literature for years.
Much investigation has focused on acetamino-
phen’s inhibition of prostaglandin (PG) synthesis,
because its analgesic and antipyretic properties re-
semble the effects of aspirin and other non-
steroidal anti-inflammatory drugs (NSAIDs).
Synthesis of prostaglandin H2 (PGH2) is a crucial
stage in arachidonic acid metabolism and is cata-
lyzed by two major forms of PGH2 synthetase
(PGHS) – constitutive PGHS-1 and inducible
PGHS-2. PGHS contains two sites: a cyclooxyge-
nase (COX) site and a peroxidase (POX) site.
Paracetamol acts as a reducing cosubstrate on the
POX site and lessens the availability of the ferryl
protoporphyrin IX radical cation, essential for
conversion of tyrosine-385 to its radical form,
which is necessary for the transformation of ara-
chidonic acid to prostaglandin G2 (PGG2) on the
COX site. What is noteworthy, this effect can be
reduced in the presence of hydroperoxide-
generating lipoxygenase enzymes within the cell
(peroxide tone) or by swamping the POX site with
substrate such as PGG2 (ANDERSON 2008). Some
hope was also associated with the discovery of a
variant of PGHS-1 (named PGHS-1b or COX-3),
sensitive to inhibition with paracetamol and active
in the cerebral cortex of canines, but subsequent
research found it improbable to play a role in PG-
mediated fever and pain in humans and mice
(CHANDRASEKHARAN et al. 2002; KIS et al. 2005).
As paracetamol seems to not have major effects
peripherically, its action appears to be mostly central.
Peroxide tone and swamping might explain the lack
of peripheral analgesic, platelet and anti-inflammatory
effects by acetaminophen but alternative PGHS
inhibition mechanisms have been also proposed
(BERTOLINI et al. 2006). Inhibition of the L-arginine
– nitric oxide (NO) pathway mediated through
substance P or N-methyl-D-aspartatic acid (NMDA),
reinforcement of descending inhibitory serotoner-
gic pain pathways and active paracetamol metabo-
lites (p-aminophenol conjugated with arachinodic
acid by fatty acid amide hydrolase forming AM404)
exerting effect through cannabinoid receptors are
postulated (ANDERSON 2008; BJORKMAN et al.
1994; BUJALSKA 2004; HOGESTATT et al. 2005;
OTTANI et al. 2006; PICKERING et al. 2008).
Hydrogen sulfide is endogenously formed from
L-cysteine in several enzymatic reactions, cata-
lyzed by cystathionine â-synthase (CBS), cys-
tathionine ã-lyase (CSE)) and 3-mercaptopyruvate
sulfurtransferase (3MST), and in non-enzymatic
pathways in many tissues, especially in the nerv-
ous, cardiovascular, digestive and excretory sys-
tems. H2S participates in the regulation of various
physiological and pathophysiological processes
including neurotransmission, immune and inflam-
matory processes, and perception (FIORUCCI et al.
2006; £OWICKA & BE£TOWSKI 2007). H2S is in-
volved in multiple nociception signaling pathways
with increasing cAMP levels in neuronal and glial
cell lines, activation of T-type calcium channel
and ATP-sensitive potassium channels (KATP),
sensitization of the NMDA receptor complex and
activation of TRPA1 (transient receptor potential
cation channel, subfamily A, member 1) ion chan-
nels (CUNHA et al. 2008; DISTRUTTI et al. 2006;
MATSUNAMI et al. 2009; SMITH 2009; STRENG et
al. 2008; TODOROVIC & JEVTOVIC-TODOROVIC
2006). Moreover, H2S interacts with NO and car-
bon monoxide (CO) in a complex manner includ-
ing affecting each other’s synthesis and biological
responses within target tissues and organs depend-
ing on specific environmental circumstances (LI et al.
2009). H2S has been shown to display various ef-
fects which promote neutrophil migration,
upregulation of COX-2 and production of inflam-
matory mediators with prostaglandin E2 (PGE2)
which appears to act on nociceptor membranes
(CUNHA et al. 1992; HU et al. 2008; SMITH 2009).
On the other hand, it is has been suggested that H2S
could be produced in the inflammatory site by mi-
grating leukocytes (CUNHA et al. 2008).
As we have demonstrated, paracetamol elicits
changes in H2S tissue concentrations reflecting al-
terations in the transmitter generation. Since H2S
has been recognized to be involved in a wide vari-
ety of processes of nociception with its predomi-
nant role of activation of T-type calcium channels
leading to facilitation of pronociceptive actions,
the observation that acetaminophen decreases the
H2S level is quite an enticing finding (ANDERSON
2008). The role of H2S mediation of paracetamol’s
central analgetic effects is definitely a field for fu-
ture research, especially when considering com-
mon features in the biological action of
acetaminophen and H2S such as involvement of
the NMDA receptor, transient receptor potential
vanilloid (TRPV) ion channels system and NO.
Secondly, H2S tissue concentration changes in
heart, liver and kidneys indicate that paracetamol
exerts peripheral effects in different organs with
possible involvement of PGHS. Interaction be-
tween prostaglandins and H2S seems to be com-
plex, including each other’s generation and
effects. Moreover, it appears that effects of H2S
vary depending on the environment and circum-
stances under which it co-acts with other messen-
gers in the specific setting of different organs.
Paracetamol is another drug shown to affect H2S
production next to NSAIDs and angiotensin-
converting enzyme inhibitor (ACEI) ramipril, en-
couraging further research of the messenger role in
physiology and pathology of different systems
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(FIORUCCI et al. 2007; SREBRO et al. 2006;
WILIÑSKI et al. 2010; WILIÑSKI et al. 2008).
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